Wellcome Sanger Institute Best Practice - the Nagoya Protocol and Access and Benefit Sharing (ABS) | ABSCH-A19A20-SCBD-262671 | Clauses contractuelles types, codes de conduite volontaires, lignes directrices et bonnes pratiques et/ou normes | Access and Benefit-Sharing Clearing-House
Access and Benefit-Sharing Clearing-HouseAccess and Benefit-Sharing Clearing-House/fr/
Session expirée Votre session a expirée, veuillez vous connecter pour continuer.
La connexion a échoué L’adresse courriel et/ou le mot de passe entré (s) sont incorrects.
Échec de l’opération. Le service n'est pas disponible. Veuillez essayer de nouveau.
This document has been produced in order to provide assurance to Nagoya Protocol member states, regulators, researchers, collaborators and peers, that the Wellcome Sanger Institute has initiated and carries out appropriate processes and procedures to enable compliance with global Access and Benefit Sharing (hereafter; ABS) measures and compliance with the UK ABS legislation5 implementing the Nagoya Protocol1 for scientific research undertaken. Within this document are the tools, processes and procedures, comprising Institute policy, that when employed correctly staff and associates of the Wellcome Sanger Institute can be confident that they are conducting their research in accordance with the UK ABS legislation and in turn, ABS legislation in force globally.
